Table 1.

Patient and tumor characteristics.

Variable	BCG treatment
Age (years)
50–59	7/24 (29.2%)
60–69	8/24 (33.3%)
70–79	9/24 (37.5%)
Gender
Male	21/24 (87.5%)
Female	3/24 (12.5%)
No. of tumors
Single	10/24 (41.7%)
Multiple	14/24 (58.3%)
Tumor size (d/cm)
0–3	15/24 (62.5%)
≥3	9/24 (37.5%)
T category
Ta	13/24 (54.2%)
T1	11/24 (45.8%)
Grade
G2	10/24 (41.7%)
G3	14/24 (58.3%)
CIS
Yes	5/24 (20.8%)
No	19/24 (79.2%)
EORTC recurrence score
≤9 (intermediate risk)	22/24 (91.7%)
10–17 (high risk)	2/24 (8.3%)
EORTC progression score
≤6 (intermediate risk)	10/24 (41.7%)
7–23 (high risk)	14/24 (58.3%)